Abstract
Genomic and proteomic technologies have become integral components of precision medicine, revolutionizing the field of cardiovascular disease management. These advanced technologies play a crucial role in enhancing screening accuracy, risk stratification, and the development of precise drugs and treatments for heart-related diseases. By leveraging gene and protein profile data, these technologies enable a more profound understanding of cardiovascular diseases, leading to more effective prevention and treatment strategies. Moreover, they facilitate the identification of individual genotype-phenotype differences, allowing for the creation of tailored cardiovascular prevention plans. Additionally, gene and protein technology holds promise in the development of novel drugs specifically designed to target complex, genetic cardiovascular diseases. However, it is important to exercise caution when applying gene and protein technology in cardiology, considering factors such as accuracy, cost, and accessibility. This article provides a comprehensive overview of the current and potential applications of gene and protein technology in managing and improving cardiovascular disease outcomes.
